Previous Pradaxa Settlement Encourages Xarelto Lawsuit Plaintiffs

BloodThinnerHelp.com reports on the status of the current Multidistrict Litigation (MDL) that consolidated the more than 2,800 Xarelto lawsuits filed against Bayer AG and the subsidiary company of the Johnson and Johnson Corporation, Janssen Pharmaceuticals. MDL 2592 is being overseen by the Honorable Judge Eldon E. Fallon of the Eastern District of Louisiana.

The plaintiffs involved in all the cases in the MDL are making similar allegations against the drug's manufacturers that the blood thinner Xarelto can induce very sudden and spontaneous internal uncontrollable bleeding that has resulted in many fatalities as well. Judge Fallon has set a target date of spring 2017 to commence the first 4 bellwether trials against the defendants to be selected out of a pool of 40 bellwether cases.

As the MDL inches toward the beginning of the litigation process, 400 more cases have been added to it just in the month of August 2015 alone.

The cases that are the focus of the MDL are not the only ones that are progressing forward as a group litigation. The Court of Common Pleas in Philadelphia, PA has created a mass tort program comprised of 550 cases with all of them naming Janssen and Bayer as defendants claiming similar allegations related to uncontrollable bleeding.

Xarelto plaintiffs are somewhat encouraged in their efforts based on actions taken with Pradaxa, also a new-generation blood thinner drug that experienced the same kind of public scrutiny that Xarelto is now getting. Pradaxa was released on the market by Boehringer Ingelheim in 2010 and it quickly became the focus of more than 4,000 lawsuits because of thousands of adverse event reports that were filed and of which 750 were reporting fatalities. Xarelto plaintiffs are hopeful that what happened with Pradaxa will happen in their situation where on the eve of the start of the trial against Pradaxa's manufacturer, it announced a $650 million settlement in lieu of going to trial.

The Osborne firm is offering free consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. Call (866) 425-8902 for more information about this release or the Xarelto litigation.